nanoComposix Signs Agreement with i-DNA Biotechnology Pte. Ltd.
nanoComposix Signs Agreement with i-DNA Biotechnology Pte. Ltd. for Distribution of its Products in Singapore and Malaysia. nanoComposix announced it that has selected and signed an agreement with i-DNA Biotechnology Pte. Ltd. for distribution of nanoComposix nanotechnology products and services in Southeast Asia. nanoComposix is a 12 year old company that provides monodisperse and unagglomerated metal and metal-oxide nanomaterials to thousands of customers worldwide. The company has hundreds of different variants of material, size, shape, and surface are available as stock products and has produced over 2000 custom core/shell, biofunctionalized, fluorescent, and magnetic nanocomposites to meet client specifications. NanoComposix produced the NIST nanosilver reference material and its particles have been utilized in over 400 peer-reviewed publications. All materials are supplied with certificates of analysis that include electron microscopy, hydrodynamic diameter, and optical data for each batch to guarantee products meet specifications. Contract manufacturing is performed on scales that range from small beakers to thousands of liters. Nanomaterials for medical devices and clinical trials are produced in our ISO13485 and cGMP compliant cleanroom facility. By leveraging our unique library of nanomaterials, we aim to help our customers rapidly bring nano-enabled products from concept to commercialization.